The FDA said that pooled testing of donations using a screening test that it has licensed is a sufficient method for complying with its testing regulations.
A combined assay to screen blood donations for HIV and hepatitis viruses and a test for West Nile virus are now cleared to run on the Procleix Panther system.
Despite the astronomical costs, it may prove challenging to reverse course and discontinue Zika testing according to a commentary article accompanying a NEJM study.
The test is designed to detect 14 of the most prevalent mutations in the gene responsible for the disease.
The assay runs on the Procleix Panther system and detects B. microti, B. duncani, B. divergens, and B. venatorum parasites that can be transmitted by tick bites or blood donation.
Hologic's CEO said in December that the blood screening business was a drag on the company's growth.
Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.
Through their arrangement, Singulex has granted Grifols an exclusive license to its single-molecule counting technology for use in blood donor and plasma screening.
The firm's blood screening revenues received a boost from services performed for the Japanese Red Cross Society by its partner, Grifols.
In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.
Researchers have developed a way to quickly edit white blood cells, according to the New York Times.
In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.
Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.